Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker
S. 527IntroducedSenate · nowHousePresidentLawIn committee
Sec. 4 · S. 527

Report

Read this section in the full bill →

No wording changed between Introduced and Committee version.

How the text changed

Before / AfterRedline
Introduced · Sec. 4

The Commission shall submit to the appropriate committees of Congress a report that includes— (1) the number and nature of complaints received by the Commission relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug; (2) the ability of the Commission to bring an enforcement action against a manufacturer of a sole-source drug; and (3) policy or legislative recommendations to strengthen enforcement actions relating to anticompetitive behavior.

•S 527 ISSEC. 4
Committee version · Sec. 4

The Commission shall submit to the appropriate committees of Congress a report that includes— (1) the number and nature of complaints received by the Commission relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug; (2) the ability of the Commission to bring an enforcement action against a manufacturer of a sole-source drug; and (3) policy or legislative recommendations to strengthen enforcement actions relating to anticompetitive behavior.

•S 527 RSSEC. 4

added wordsremoved wordsComparison computed by Public Law Tracker from the official text